Oral Session 2-11D CML: Basic (2)

[OS2-11D-6] Silent NK & T reactions during sustained DMR is significant for longer TRF after dasatinib cessation

Takashi Kumagai¹, Chiaki Nakaseko², Kaichi Nishiwaki³, Chikashi Yoshida⁴, Kazuteru Ohashi⁵, Naoki Takezako⁶, Hina Takano⁷, Yasuji Kouzai⁸, Tadashi Murase⁹, Kosei Matsue¹⁰, Satoshi Morita¹¹, Junichi Sakamoto¹², Hisashi Wakita¹³, Hisashi Sakamaki⁵, Koichi Inokuchi¹⁴ (1.Department of Hematology, Ome Municipal General Hospital, Ome, Japan, 2.Department of Hematology, Chiba University Hospital, Chiba, Japan, 3.Clinical Oncology and Hematology, Jikei University, Kashiwa Hospital, Chiba, Japan, 4.Dept. Hematology, National Hospital Organization, Mito Medical Center, Higashiibarakigun, Japan, 5.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 6.Dept. Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Japan, 7.Department of Hematology, Musashino Red Cross Hospital, Musashino, Japan, 8.Dept. Hematology, Tokyo Metropolitan Tama Synthesis Medical Center, Tokyo, Japan, 9.Dept. Laboratory Medicine, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan, 10.Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan, 11.Dept. Biomedical Statistics and Bioinformatics, Kyoto University Graduate, Kyoto, Japan, 12.Tokai Central Hospital, Kakamigahara, Japan, 13.Division of Hematology/Oncology, Narita Red Cross Hosp., Narita, Japan, 14.Department of Hematology, Nippon Medical School, Tokyo, Japan)